Our recent study showed a notable trend of improvemed FSIQ and a significant gain in reading comprehension in 19 patients with SCD (aged 7.2–17.8 years), comparing before and after 1 year of hydroxyurea treatment [ 15 ].
← all excerpts
Hydroxyurea maintains working memory function in pediatric sickle cell disease.
1
—
—